Cargando…

NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity

It is known that T cells can eliminate tumour cells through recognition of unique or aberrantly expressed antigens presented as peptide epitopes by major histocompatibility complex (MHC) molecules on the tumour cell surface. With recent advances in defining tumour-associated antigens, it should now...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Regan J., Compton, Benjamin J., Tang, Ching-wen, Authier-Hall, Astrid, Hayman, Colin M., Swinerd, Gene W., Kowalczyk, Renata, Harris, Paul, Brimble, Margaret A., Larsen, David S., Gasser, Olivier, Weinkove, Robert, Hermans, Ian F., Painter, Gavin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal Society of Chemistry 2015
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500832/ https://www.ncbi.nlm.nih.gov/pubmed/28717498 http://dx.doi.org/10.1039/c4sc03599b

Ejemplares similares

Glycolipid-peptide conjugate vaccines enhance CD8(+) T cell responses against human viral proteins
por: Speir, M., et al.
Publicado: (2017)

Harnessing NKT cells for vaccination
por: Burn, Olivia K, et al.
Publicado: (2021)

Glycolipid‐peptide conjugate vaccines elicit CD8 (+) T‐cell responses and prevent breast cancer metastasis
por: Burn, Olivia K, et al.
Publicado: (2022)

Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy
por: Jarvis, Ellie-May, et al.
Publicado: (2021)

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

Tailored design of NKT-stimulatory glycolipids for polarization of immune responses
por: Hung, Jung-Tung, et al.
Publicado: (2017)

Invariant NKT cells recognize glycolipids from pathogenic Gram-positive bacteria
por: Kinjo, Yuki, et al.
Publicado: (2011)

22511 Glycolipid-loaded nanoparticles harness iNKT cells for tumor immunotherapy
por: Shute, Travis, et al.
Publicado: (2021)

A Rapid Fluorescence-Based Assay for Classification of iNKT Cell Activating Glycolipids
por: Arora, Pooja, et al.
Publicado: (2011)

First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis
por: Sato, Wakiro, et al.
Publicado: (2023)

Improving Mycobacterium bovis Bacillus Calmette-Guèrin as a Vaccine Delivery Vector for Viral Antigens by Incorporation of Glycolipid Activators of NKT Cells
por: Venkataswamy, Manjunatha M., et al.
Publicado: (2014)

Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2022)

A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR
por: Wun, Kwok S., et al.
Publicado: (2008)

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells
por: Shimizu, Kanako, et al.
Publicado: (2015)

Implications of Lymphocyte Anergy to Glycolipids in Multiple Sclerosis (MS): iNKT Cells May Mediate the MS Infectious Trigger
por: Hogan, Edward L, et al.
Publicado: (2013)

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma
por: Dasyam, Nathaniel, et al.
Publicado: (2023)

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013)

Activation of Invariant NKT Cells with Glycolipid Ligand α-Galactosylceramide Ameliorates Glucose-6-Phosphate Isomerase Peptide-Induced Arthritis
por: Horikoshi, Masanobu, et al.
Publicado: (2012)

A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition
por: Kjer-Nielsen, Lars, et al.
Publicado: (2006)

Distinct Dysfunctional States of Circulating Innate-Like T Cells in Metabolic Disease
por: Li, Yanyan, et al.
Publicado: (2020)

The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode
por: Li, Yali, et al.
Publicado: (2010)

The Liganding of Glycolipid Transfer Protein Is Controlled by Glycolipid Acyl Structure
por: Malinina, Lucy, et al.
Publicado: (2006)

How Spacecraft Fly: Spaceflight Without Formulae
por: Swinerd, Graham
Publicado: (2009)

Glycolipids anchor laminin
por: Tuma, Rabiya S.
Publicado: (2005)

Contributions of Glycolipid Biosurfactants and Glycolipid-Modified Materials to Antimicrobial Strategy: A Review
por: Shu, Qin, et al.
Publicado: (2021)

PGL-III, a Rare Intermediate of Mycobacterium leprae Phenolic Glycolipid Biosynthesis, Is a Potent Mincle Ligand
por: Ishizuka, Shigenari, et al.
Publicado: (2023)

Glycolipids of human primary testicular germ cell tumours.
por: Olie, R. A., et al.
Publicado: (1996)

Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells
por: Salio, Mariolina, et al.
Publicado: (2017)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

Combining OSMAC Approach and Untargeted Metabolomics for the Identification of New Glycolipids with Potent Antiviral Activity Produced by a Marine Rhodococcus
por: Palma Esposito, Fortunato, et al.
Publicado: (2021)

NKT Cells in Sepsis
por: Leung, Briana, et al.
Publicado: (2010)

Decreased glycolipid antigen expression in lymphoma cell variants escaping from anti-glycolipid serotherapy
Publicado: (1983)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1- and NKT2-Type iNKT Cells
por: Yasuoka, Toshiaki, et al.
Publicado: (2016)

Relationships between Th1 or Th2 iNKT Cell Activity and Structures of CD1d-Antigen Complexes: Meta-analysis of CD1d-Glycolipids Dynamics Simulations
por: Laurent, Xavier, et al.
Publicado: (2014)

Natural Killer T (NKT) Cells and Periodontitis: Potential Regulatory Role of NKT10 Cells
por: Melgar-Rodríguez, Samanta, et al.
Publicado: (2021)

Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines
por: Khan, Masood Alam, et al.
Publicado: (2021)

The IL-10 and IFN-γ pathways are essential to the potent immunosuppressive activity of cultured CD8(+ )NKT-like cells
por: Zhou, Li, et al.
Publicado: (2008)

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells
por: Watkinson, Fiona, et al.
Publicado: (2021)

Capping of exogenous Forssman glycolipid on cells
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_b4g0kqkea2b0sj7m5s7hivji36